1-19 of 19
Weiyun Z. Ai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Metabolic Tumor Volume Predicts Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Loncastuximab Tesirine in the Lotis-2 Trial

Juan Pablo Alderuccio, Russ A Kuker, Isildinha M Reis, Muthiah Nachiappan, Brad S. Kahl, Mehdi Hamadani, Weiyun Z. Ai, John Radford, Melhem Solh, Kirit M. Ardeshna, Brian T. Hess, Matthew A. Lunning, Pier Luigi Zinzani, Anastasios Stathis, Carmelo Carlo-Stella, Eric Yu, Paolo F Caimi, Deukwoo Kwon, Izidore S. Lossos, Fei Yang, Craig H. Moskowitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 6650–6652.
https://doi.org/10.1182/blood-2022-162758
Published: 2022
Journal Articles

NX-2127-001, a First-in-Human Trial of NX-2127, a Bruton's Tyrosine Kinase-Targeted Protein Degrader, in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and B-Cell Malignancies

Anthony R. Mato, William G. Wierda, Weiyun Z. Ai, Ian W. Flinn, Michael Tees, Manish R. Patel, Krish Patel, Susan O'Brien, David A. Bond, Lindsey E. Roeker, Tanya Siddiqi, Michael L. Wang, Clare Sun, Omar Abdel-Wahab, Amanda Schwab, May Tan, Erin Meredith, Melissa A. Gessner, Su Young Kim, Adrian Wiestner, Alexey V Danilov
Journal: Blood
Blood (2022) 140 (Supplement 1): 2329–2332.
https://doi.org/10.1182/blood-2022-164772
Published: 2022
Journal Articles

Clinical Characteristics and Responses of Patients with Relapsed or Refractory High-Grade B-Cell Lymphoma Treated with Loncastuximab Tesirine in the Lotis-2 Clinical Trial

Juan Pablo Alderuccio, Weiyun Z. Ai, John Radford, Melhem Solh, Kirit M. Ardeshna, Matthew A. Lunning, Brian T. Hess, Pier Luigi Zinzani, Anastasios Stathis, Carmelo Carlo-Stella, Mehdi Hamadani, Brad S. Kahl, David Ungar, Turk Kilavuz, Eric Yu, Yajuan Qin, Paolo F. Caimi
Journal: Blood
Blood (2021) 138 (Supplement 1): 3575.
https://doi.org/10.1182/blood-2021-148730
Published: 2021
Journal Articles

The Anti-CD19 Antibody-Drug Conjugate Loncastuximab Tesirine Achieved Responses in Patients with Diffuse Large B-Cell Lymphoma Who Relapsed after Anti-CD19 CAR T-Cell Therapy

Paolo F. Caimi, Kirit M. Ardeshna, Erin Reid, Weiyun Z. Ai, Matthew A. Lunning, Jasmine Zain, Melhem Solh, Brad S. Kahl, Mehdi Hamadani
Journal: Blood
Blood (2021) 138 (Supplement 1): 2489.
https://doi.org/10.1182/blood-2021-153591
Published: 2021
Journal Articles

Safety and Efficacy of Tenalisib Given in Combination with Romidepsin in Patients with Relapsed/Refractory T-Cell Lymphoma: Final Results from a Phase I/II Open Label Multi-Center Study

Swaminathan P Iyer, Auris Huen, Weiyun Z. Ai, Deepa Jagadeesh, Mary Jo Lechowicz, Craig Okada, Tatyana A. Feldman, Suchitra Sundaram, Juan Pablo Alderuccio, Nishitha Reddy, Don Stevens, Timothy M. Kuzel, Ann Mohrbacher, Kasi Viswanath Routhu, Prajak Barde, Ajit Mohanchandran Nair, Brad M. Haverkos
Journal: Blood
Blood (2021) 138 (Supplement 1): 1365.
https://doi.org/10.1182/blood-2021-145851
Published: 2021
Journal Articles

Evaluation of Pulmonary Toxicities in Lymphoma Patients Receiving Brentuximab Vedotin

Tiffany Guan, Mimi Lo, Rebecca Young, Fouad Boulbol, Hanson Mouanoutoua, Raymond Chu, Weiyun Z. Ai, Haifaa Abdulhaq, Bita Fakhri
Journal: Blood
Blood (2021) 138 (Supplement 1): 2511.
https://doi.org/10.1182/blood-2021-151420
Published: 2021
Journal Articles

A Multi-Center, Open Label, Phase I/II Study to Assess the Safety and Efficacy of Tenalisib Given in Combination with Romidepsin in Patients with Relapsed/Refractory T-Cell Lymphoma

Swami P. Iyer, MD, Auris Huen, MD, Bradley Haverkos, MD MPH, MS, Weiyun Z. Ai, Craig Okada, MD PhD, Timothy M. Kuzel, MD, Mary Jo Lechowicz, MD, Juan Pablo Alderuccio, MD, Ann Mohrbacher, MD, Don A. Stevens, MD, Ryan A. Wilcox, MD, Tatyana A. Feldman, MD, Suchitra Sundaram, MD, Deepa Jagadeesh, MDMPH, Nishitha Reddy, MD MSCI, Kasi Viswanath Routhu, PhD, Prajak Barde, MD, Ajit Mohanchandran Nair, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–10.
https://doi.org/10.1182/blood-2020-136018
Published: 2020
Journal Articles

Efficacy and Safety of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Paolo F Caimi, Weiyun Z. Ai, Juan Pablo Alderuccio, MD, Kirit M. Ardeshna, Mehdi Hamadani, MD, Brian T. Hess, MD, Brad S. Kahl, MD, John A. Radford, MD FMedSci, Melhem Solh, MD, Anastasios Stathis, MD, Pier Luigi Zinzani, MD, Jay Feingold, David Ungar, Yajuan Qin, Shui He, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–37.
https://doi.org/10.1182/blood-2020-137524
Published: 2020
Journal Articles

Infectious Complications of BCMA-Targeted and CD19-Targeted Chimeric Antigen Receptor T-Cell Immunotherapy

Swetha Kambhampati, MD, Bita Fakhri, MDMPH, Ying Sheng, Chiung-Yu Huang, PhD, Sophia Byslma, BS, Kelsey Natsuhara, MD, Dhruba Biswas, Mimi Lo, PharmD, BCPS, BCOP, Weiyun Z. Ai, Lawrence D Kaplan, MD, Thomas Martin, III, MD, Jeffrey L. Wolf, MD, Nina Shah, MD, Charalambos Andreadis, MD MSCE, Sandy W. Wong, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-138940
Published: 2020
Journal Articles

Development of a Pathway-Directed Drug Screen Platform for Cutaneous T Cell Lymphoma Using Patient-Derived Xenograft Models

CHI-HENG WU, PhD, Chen-Yen Yang, PhD, Linlin Wang, MD PhD, Hua-Xin Gao, PhD, Rakhshandehroo Taha, Shervin Afghani, Laura Pincus, MD, Ronald Balassanian, MD, James Rubenstein, Ryan Gill, MD PhD, Sourav Bandyopadhyay, PhD, Frank McCormick, PhD, Mark Moasser, MD, Weiyun Z. Ai, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1578.
https://doi.org/10.1182/blood-2019-122589
Published: 2019
Journal Articles

Cell of Origin and Double Protein Expression As Predictors of Outcome after Autologous Stem Cell Transplant for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Who Undergo Intensive Consolidation Therapy (ICT) and Autologous Stem Cell Transplant (AutoSCT)

Bradley Hunter, MD MPH, Ben Rosen, MD, Miguel Castillo, Lawrence D. Kaplan, MD, Weiyun Z. Ai, MD PhD, Lloyd E. Damon, MD, Thomas G. Martin, III, MD, Charalambos Andreadis, MD MSCE
Journal: Blood
Blood (2016) 128 (22): 4638.
https://doi.org/10.1182/blood.V128.22.4638.4638
Published: 2016
Journal Articles

Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk Following Autologous Hematopoietic Cell Transplantation

Gabriel N. Mannis, MD, Thomas G. Martin, III, MD, Lloyd E. Damon, MD, Charalambos Andreadis, MD MSCE, Rebecca L. Olin, MD MSCE, Katie Kong, Malek Faham, MD PhD, Weiyun Z. Ai, MD PhD, Karin ML Gaensler, MD, Peter H. Sayre, MD PhD, Jeffrey L. Wolf, MD PhD, Aaron C. Logan, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1420.
https://doi.org/10.1182/blood.V126.23.1420.1420
Published: 2015
Journal Articles

Delayed Hematopoietic Recovery After Autologous Stem Cell Transplantation In Patients Receiving Arsenic Trioxide-Based Therapy For Acute Promyelocytic Leukemia

Gabriel N. Mannis, MD, Lloyd E Damon, MD, Weiyun Z. Ai, MD, PhD, Charalambos Andreadis, MD, MS, Karin ML Gaensler, MD, Neel K. Gupta, M.D., Lawrence D. Kaplan, M.D., Andrew D. Leavitt, MD, Aaron C. Logan, MD, PhD, Rebecca L. Olin, MD, MS, Peter H. Sayre, MD, PhD, Catherine C Smith, MD, Jeffrey M Venstrom, MD, Thomas G Martin, III, MD
Journal: Blood
Blood (2013) 122 (21): 2172.
https://doi.org/10.1182/blood.V122.21.2172.2172
Published: 2013
Journal Articles

Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program

Zijun Y. Xu-Monette, PhD, Bouthaina S. Dabaja, MD, Alexander Tzankov, MD, PhD, Carlo Visco, MD, Roberto N. Miranda, MD, Karen Dybkaer, PhD, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD, PhD, Govind Bhagat, MD, Kristy L. Richards, MD PhD, Eric D. Hsi, MD, Wai Lap Choi, MD, Joannes H.J.M. Van Krieken, PhD, MD, Jooryung Huh, MD, Weiyun Z. Ai, MD, PhD, Maurilio Ponzoni, MD, Andres Ferreri, MD, PhD, Michael B. Moller, MD, PhD, Xiaoying Zhao, MD, Ronald S. Go, MD, Jane N. Winter, MD, Miguel Angel A. Piris, MD, PhD, Timothy J. McDonnell, MD, PhD, Yong Li, PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 213.
https://doi.org/10.1182/blood.V122.21.213.213
Published: 2013
Journal Articles

STAT3 Expression and Clinical Implications In De Novo Diffuse Large B-Cell Lymphoma: A Report From The International DLBCL Rituximab-CHOP Consortium Program

Chi Young Ok, MD, Zijun Y. Xu-Monette, PhD, Alexander Tzankov, MD, PhD, Carlo Visco, MD, Santiago M. Montes, MD, PhD, Karen Dybkaer, PhD, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD, PhD, Govind Bhagat, MD, PhD, Kristy L. Richards, MD PhD, Eric D. Hsi, MD, William W. L. Choi, MD, PhD, Joannes H.J.M. Van Krieken, PhD, MD, Qin Huang, MD, PhD, Jooryung Huh, MD, Weiyun Z. Ai, MD, PhD, Maurilio Ponzoni, MD, AndrÉs J.M. Ferreri,, MD, PhD, John P. Farnen, MD, FACP, Michael B. Moller, MD, PhD, Jane N. Winter, MD, Miguel A. Piris, MD, PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 365.
https://doi.org/10.1182/blood.V122.21.365.365
Published: 2013
Journal Articles

MYC Mutation Profiling In 708 De Novo Diffuse Large B-Cell Lymphoma Demonstrates That Genetic Abnormalities In The Coding Sequence and Untranslated Regions Have Different Prognostic and Clinical Significance: A Report From The International DLBCL Rituximab-CHOP Consortium Program

Zijun Y. Xu-Monette, PhD, Alexander Tzankov, MD, Yong Li, PhD, Carlo Visco, MD, Santiago Montes-Moreno, MD, PhD, Karen Dybkaer, PhD, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD, PhD, Govind Bhagat, MD, Kristy L. Richards, MD PhD, Eric D. Hsi, MD, William W. L. Choi, MD, PhD, Joannes H.J.M. Van Krieken, PhD, MD, Jooryung Huh, MD, Weiyun Z. Ai, MD, PhD, Maurilio Ponzoni, MD, Andres J.M. Ferreri, MD, PhD, John P. Farnen, MD, FACP, Michael B. Moller, MD, PhD, Jane N. Winter, MD, Miguel A. Piris, MD, PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 363.
https://doi.org/10.1182/blood.V122.21.363.363
Published: 2013
Journal Articles

Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program

Zijun Y. Xu-Monette, PhD, Bouthaina S. Dabaja, MD, Alexander Tzankov, MD, PhD, Carlo Visco, MD, Roberto N. Miranda, MD, Karen Dybkaer, PhD, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD, PhD, Govind Bhagat, MD, Kristy L. Richards, MD PhD, Eric D. Hsi, MD, Wai Lap Choi, MD, Joannes H.J.M. Van Krieken, PhD, MD, Jooryung Huh, MD, Weiyun Z. Ai, MD, PhD, Maurilio Ponzoni, MD, Andres Ferreri, MD, PhD, Michael B. Moller, MD, PhD, Xiaoying Zhao, MD, Ronald S. Go, MD, Jane N. Winter, MD, Miguel Angel A. Piris, MD, PhD, Timothy J. McDonnell, MD, PhD, Yong Li, PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 641.
https://doi.org/10.1182/blood.V122.21.641.641
Published: 2013
Journal Articles

In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study

Clinical Trials & Observations
Youn H. Kim, Dita Gratzinger, Cameron Harrison, Joshua D. Brody, Debra K. Czerwinski, Weiyun Z. Ai, Anjali Morales, Farah Abdulla, Leon Xing, Daniel Navi, Robert J. Tibshirani, Ranjana H. Advani, Bharathi Lingala, Sumit Shah, Richard T. Hoppe, Ronald Levy
Journal: Blood
Blood (2012) 119 (2): 355–363.
https://doi.org/10.1182/blood-2011-05-355222
Published: 2012
Journal Articles

Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma

Brief Report
Weiyun Z. Ai, Robert Tibshirani, Behnaz Taidi, Debra Czerwinski, Ronald Levy
Journal: Blood
Blood (2009) 113 (23): 5743–5746.
https://doi.org/10.1182/blood-2009-01-201988
Published: 2009
Includes: Supplemental data